These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9763933)

  • 1. Antituberculosis drug resistance worldwide.
    Wkly Epidemiol Rec; 1998 Aug; 73(33):249-54. PubMed ID: 9763933
    [No Abstract]   [Full Text] [Related]  

  • 2. Antituberculosis drug resistance worldwide.
    Wkly Epidemiol Rec; 2000 Mar; 75(12):95-100. PubMed ID: 10771621
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues facing TB control (7). Multiple drug-resistant tuberculosis.
    Raviglione MC
    Scott Med J; 2000 Oct; 45(5 Suppl):52-5; discussion 56. PubMed ID: 11130318
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO identifies drug-resistant tuberculosis "hotspots". Former Russian states are worst affected, but lack of data from China hides true extent of disease.
    Brown H
    Lancet; 2004 Mar; 363(9413):951. PubMed ID: 15046108
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
    Wright A; Zignol M; Van Deun A; Falzon D; Gerdes SR; Feldman K; Hoffner S; Drobniewski F; Barrera L; van Soolingen D; Boulabhal F; Paramasivan CN; Kam KM; Mitarai S; Nunn P; Raviglione M;
    Lancet; 2009 May; 373(9678):1861-73. PubMed ID: 19375159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
    Aziz MA; Wright A; Laszlo A; De Muynck A; Portaels F; Van Deun A; Wells C; Nunn P; Blanc L; Raviglione M;
    Lancet; 2006 Dec; 368(9553):2142-54. PubMed ID: 17174706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XDR tuberculosis--implications for global public health.
    Raviglione MC; Smith IM
    N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
    [No Abstract]   [Full Text] [Related]  

  • 8. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Pablos-Méndez A; Raviglione MC; Laszlo A; Binkin N; Rieder HL; Bustreo F; Cohn DL; Lambregts-van Weezenbeek CS; Kim SJ; Chaulet P; Nunn P
    N Engl J Med; 1998 Jun; 338(23):1641-9. PubMed ID: 9614254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XDR-TB or not XDR-TB? That is the question.
    Bateman C
    S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208
    [No Abstract]   [Full Text] [Related]  

  • 10. Global killer.
    Hill B
    Nurs Stand; 2001 May 30-Jun 5; 15(37):22. PubMed ID: 12205762
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of antituberculosis drug resistance in Saudi Arabia 1979-98.
    Abu-Amero KK
    East Mediterr Health J; 2002; 8(4-5):664-70. PubMed ID: 15603050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining priorities: swine-origin H1N1 and the MDR-TB epidemic.
    Migliori GB; Sotgiu G; Lange C; Macgregor-Skinner G
    Lancet; 2009 Jun; 373(9681):2108. PubMed ID: 19541029
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living the TB resistance nightmare.
    Bateman C
    S Afr Med J; 2006 Oct; 96(10):1014-6. PubMed ID: 17164928
    [No Abstract]   [Full Text] [Related]  

  • 16. Scratching the surface of ignorance on MDR tuberculosis.
    Borgdorff MW; Small PM
    Lancet; 2009 May; 373(9678):1822-4. PubMed ID: 19375157
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance.
    Kaye K; Frieden TR
    Epidemiol Rev; 1996; 18(1):52-63. PubMed ID: 8877330
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-resistant tuberculosis: World Health Organization launches global response plan 2007-2008.
    Euro Surveill; 2007 Jul; 12(7):E070705.3. PubMed ID: 17868565
    [No Abstract]   [Full Text] [Related]  

  • 19. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.
    Raviglione MC; Snider DE; Kochi A
    JAMA; 1995 Jan; 273(3):220-6. PubMed ID: 7807661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antituberculosis drug resistance: is it worth measuring? The WHO/IUATLD Working Group on Antituberculosis Drug Resistance Surveillance.
    Bustreo F; Migliori GB; Nardini S; Raviglione MC
    Monaldi Arch Chest Dis; 1996 Aug; 51(4):299-302. PubMed ID: 8909014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.